Product image of Maxalt Smelt (Rizatriptan Benzoate) supplied by GNH India

Maxalt Smelt

Active Ingredient:
Rizatriptan Benzoate
Origin:
EU

Maxalt Smelt (Rizatriptan Benzoate)

Rizatriptan, the active ingredient in Maxalt Smelt, is a Triptan (5‑HT1B/1D receptor agonist) presented as an oral tablet for oral use. It is indicated for the acute treatment of migraine attacks, with or without aura, in adult patients.\n\nGNH India supplies Maxalt Smelt as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

N.V. Organon

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Rizatriptan belongs to the Triptan class and is used to treat migraine attacks.\n\nMigraine (with or without aura): Provides rapid relief by aborting the headache phase of a migraine episode.\nMigraine prophylaxis: Not indicated; the drug is intended for acute, not preventive, therapy.\nOther headache disorders: Not approved; use is limited to migraine.

How It Works

  • Rizatriptan selectively binds to serotonin 5‑HT1B and 5‑HT1D receptors on intracranial blood vessels and sensory nerve terminals. Activation of these receptors produces cranial vasoconstriction and inhibits the release of pro‑inflammatory neuropeptides, thereby interrupting the cascade that generates migraine pain and associated symptoms.

Side Effects

  • Rizatriptan may cause a range of adverse reactions, most of which are mild and transient.\n\nCommon Side Effects:\n- Nausea\n- Dizziness\n- Fatigue\n- Dry mouth\n- Tingling or numbness in the fingers or toes\n- Chest discomfort or pressure\n\nSerious or Rare Side Effects:\n- Coronary artery spasm leading to chest pain or myocardial infarction\n- Serotonin syndrome, especially when combined with other serotonergic agents\n- Severe hypertension\n- Allergic reactions such as rash, angioedema, or anaphylaxis\n- Stroke or transient ischemic attack

Precautions & Warnings

  • Before prescribing Maxalt Smelt, clinicians should evaluate cardiovascular risk and concomitant medication use.\n\nCardiovascular disease: Avoid in patients with uncontrolled hypertension, coronary artery disease, or history of myocardial infarction.\nHemiplegic or basilar migraine: Contraindicated due to increased risk of cerebrovascular events.\nConcomitant serotonergic drugs: Use caution to prevent serotonin syndrome.\nPregnancy and lactation: Safety not established; prescribe only if benefit outweighs potential risk.\nDrug interactions: Review all current medications for potential interactions.\nStore at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

  • Rizatriptan can interact with several drug classes, requiring careful management.\n\nMajor Interactions (Avoid):\n- Monoamine oxidase inhibitors (MAOIs) taken within 14 days\n- Other triptans or ergot derivatives (risk of additive vasoconstriction)\n- Selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs) (risk of serotonin syndrome)\n\nModerate Interactions (Monitor Closely):\n- Antihypertensive agents (possible additive blood pressure effects)\n- Strong CYP3A4 inhibitors (may increase rizatriptan plasma levels)\n- Oral contraceptives (potential for altered efficacy)\n- Antihistamines or sedatives (may enhance dizziness or fatigue)

Frequently Asked Questions

Maxalt Smelt contains rizatriptan and is prescribed for the acute treatment of migraine attacks, with or without aura, in adult patients. It works to stop a migraine once it has begun, providing relief from headache and associated symptoms such as nausea and sensitivity to light.

Rizatriptan is a selective agonist at serotonin 5‑HT1B and 5‑HT1D receptors. By stimulating these receptors, it causes constriction of dilated cranial blood vessels and blocks the release of inflammatory neuropeptides, which together abort the migraine cascade and reduce pain.

The specific dose of Maxalt Smelt is determined by the prescribing clinician based on the patient’s medical history, severity of migraine, and response to treatment. Standard dosing guidelines exist, but the prescriber tailors the regimen to each individual.

Safety data for rizatriptan during pregnancy and lactation are limited. The medication should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified health professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with other triptans such as sumatriptan, rizatriptan often provides a faster onset of relief and may be better tolerated by some patients. Unlike non‑specific analgesics, it targets the underlying vascular and neurogenic mechanisms of migraine, offering more specific abortive therapy.

Store Maxalt Smelt at ambient temperature below 25 °C, in the original packaging, and protect it from moisture. Keep the product out of reach of children and avoid exposure to direct sunlight or excessive heat.

Maxalt Smelt is taken orally as a tablet. The patient should swallow the tablet whole with water, preferably as soon as migraine symptoms appear. It can be taken with or without food, but excessive alcohol may increase the risk of side effects.

Serious risks include coronary artery spasm, myocardial infarction, stroke, and serotonin syndrome, especially when combined with other serotonergic drugs. Patients should seek immediate medical attention if they experience chest pain, severe hypertension, or signs of an allergic reaction.

Maxalt Smelt is contraindicated in patients with uncontrolled hypertension, a history of coronary artery disease, recent myocardial infarction, hemiplegic or basilar migraine, and those currently taking MAO inhibitors or other triptans. It should also be avoided in individuals with known hypersensitivity to rizatriptan.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Rizatriptan Benzoate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT